Article
Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease
9 Jan 2018
Abstract excerpt
BACKGROUNDS: Long non-coding RNA (LncRNA) have been reported to be involved in the pathogenesis of neurodegenerative diseases, but whether it can serve as a biomarker for Alzheimer disease (AD) is not yet known. METHODS: The present study selected four specific LncRNA (17A, 51A, BACE1 and BC200) as possible AD biomarker. RT-qPCR was performed to validate the LncRNA. Receiver operating characteristic curve (ROC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
